Basal insulin analogs mimic physiologic basal insulin secretion and reduce β-cell load [5]; glucagon-like peptide-1 receptor agonists (GLP-1RA) can improve pancreatic β-cell function and reduce pancreatic β-cell apoptosis as well as improve insulin resistance [6–8]. This evidence concerns the gene INS and Insulin resistance.